Ursa Fund Management, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
425 Market St Ste 2200 San Francisco, CA 94105
As of the latest 13F report, the guru’s equity portfolio contained 19 stocks valued at a total of $67.00Mil. The top holdings were
According to GuruFocus data, these were Ursa Fund Management, LLC’s top five trades of the quarter.
Change Healthcare Inc
The guru sold out of their 3,412,100-share investment in NAS:CHNG. Previously, the stock had a 63.39% weight in the equity portfolio. Shares traded for an average price of $27.49 during the quarter.
On 01/27/2023, Change Healthcare Inc traded for a price of $27.49 per share and a market cap of $9.03Bil. The stock has returned 30.16% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Change Healthcare Inc has a price-book ratio of 2.73, a EV-to-Ebitda ratio of 16.98 and a price-sales ratio of 2.55.
Albertsons Companies Inc
The guru established a new position worth 550,000 shares in NYSE:ACI, giving the stock a 17.02% weight in the equity portfolio. Shares traded for an average price of $21.98 during the quarter.
On 01/27/2023, Albertsons Companies Inc traded for a price of $21 per share and a market cap of $11.25Bil. The stock has returned -19.91% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Albertsons Companies Inc has a price-earnings ratio of 8.68, a price-book ratio of 13.73, a price-earnings-to-growth (PEG) ratio of 0.37, a EV-to-Ebitda ratio of 4.39 and a price-sales ratio of 0.15.
The price-to-GF Value ratio is 0.92, earning the stock a GF Value rank of 6.
Cornerstone Strategic Value Fund Inc
Ursa Fund Management, LLC reduced their investment in AMEX:CLM by 2,117,970 shares. The trade had a 12.27% impact on the equity portfolio. During the quarter, the stock traded for an average price of $8.199999999999999.
On 01/27/2023, Cornerstone Strategic Value Fund Inc traded for a price of $7.92 per share and a market cap of $1.62Bil. The stock has returned -25.89% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Cornerstone Strategic Value Fund Inc has a price-book ratio of 1.04.
iStar Inc
During the quarter, Ursa Fund Management, LLC bought 741,464 shares of NYSE:STAR for a total holding of 903,738. The trade had a 8.44% impact on the equity portfolio. During the quarter, the stock traded for an average price of $7.71.
On 01/27/2023, iStar Inc traded for a price of $9 per share and a market cap of $780.27Mil. The stock has returned -42.92% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, iStar Inc has a price-earnings ratio of 1.22, a price-book ratio of 0.46, a EV-to-Ebitda ratio of -7.12 and a price-sales ratio of 3.88.
The price-to-GF Value ratio is 1.34, earning the stock a GF Value rank of 1.
Biohaven Ltd
The guru sold out of their 50,000-share investment in NYSE:BHVN. Previously, the stock had a 5.11% weight in the equity portfolio. Shares traded for an average price of $14.12 during the quarter.
On 01/27/2023, Biohaven Ltd traded for a price of $18.54 per share and a market cap of $1.26Bil. The stock has returned 0.00% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Biohaven Ltd has a price-book ratio of 6.62 and a EV-to-Ebitda ratio of -10.68.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
